Skip to main content
Premium Trial:

Request an Annual Quote

NIAAA Seeks to Award $4M to Research Genomic, Proteomic Biomarkers of Alcoholism

NEW YORK, March 25 (GenomeWeb News) - The National Institute on Alcohol Abuse and Alcoholism has issued two requests for applications for the identification of genomic, proteomic, and metabolomic biomarkers for alcohol consumption and alcohol-induced tissue injury.

 

One RFA is open to industry, while the other is open to academic researchers.

 

The NIAAA intends to commit up to $2 million in FY2006 for each RFA. Approximately three to six awards will be made to SBIR, and 6 to 8 awards will be made to academia.

 

"The ultimate goal of the genomic, proteomic and metabolomic studies in alcohol research is to decipher the interconnecting networks of genes, proteins, and metabolites in order to understand the information flow leading to alcohol use disorders and develop clinical interventions for these diseases," the RFA for Small Business Innovation Research stated.

 

More information about the SBIR RFA can be found here, and information about the RFA for academia can be found here.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.